Day One Biopharmaceuticals Inc Net Income per Employee (DAWN), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Day One Biopharmaceuticals Inc   (NASDAQ: DAWN)
 

Day One Biopharmaceuticals Inc Net Income per Employee

DAWN's Quarterly Results, Trends, Rankings, Statistics
Day One Biopharmaceuticals Inc recorded a cumulative net loss of $-193 million during 12 month ending in the fourth quarter 2025.
The Healthcare sector has seen employees of 80 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 2271, from total ranking in previous quarter at 3466.


What is Income per Employee Ratio?






DAWN Net Income per Employee (Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -1,086,326 -1,409,393 -776,562 -444,584 -390,764
DAWN's Total Ranking # 2271 # 3466 # 2843 # 3512 # 0
Seq. Net Income Change - - - - -


DAWN Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 81
Healthcare Sector # 209
Overall Market # 2271

Net Income per Employee Statistics
High Average Low
$ 11,101 $ -511,239 $ -1,409,393
(Dec 31 2025)   (Sep 30 2025)







Companies with similar Income per Employee for 12 month ending Dec 31 2025, within Healthcare Sector Income per Employee Income 12 month ending Dec 31 2025Number of Employees Dec 31 2025


Date modified: 2026-08-29T01:18:37+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.